Pfizer’s Top Lawyer Is Out to Change All the Rules

Pfizer general counsel Amy Schulman's goals are simple and familiar: lower fees, more collaboration, better value for both the customer and vendor. By the end of 2010, Schulman wants three-fourths of her legal spending to be done within the Pfizer Legal Alliance, in which each firm is paid one annual flat fee for all of the work that it does for the entire year. If Schulman is successful, Pfizer will become one of the largest companies to have more than half of its legal work done under alternative fees.